InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-24.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Zuga Matt, Chief Financial Officer. Officer active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 9 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €45k. Activity tracked since 29 December 2022. The latest transaction was filed on 21 January 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
4,364 shares@ US$1.60096.6% of flowCommon StockSEC:0001576885-25-000037:0
13,235 shares@ US$1.841123.5% of flowCommon StockSEC:0001576885-25-000011:0
66,800 shares0Common StockSEC:0001576885-25-000011:1
4,242 shares@ US$3.70514.3% of flowCommon StockSEC:0001576885-24-000026:0
106,000 shares0Common StockSEC:0001576885-24-000010:0
33,500 shares0Common StockSEC:0001209191-23-003750:0
50,000 shares@ US$1.1955.5% of flowCommon StockSEC:0001209191-23-000327:0
26,187 sharesCommon StockSEC:0001209191-21-046031:0
26,187 sharesCommon StockSEC:0001209191-21-046031
9 of 9 declarations
About Zuga Matt
Matt Zuga serves as the Chief Financial Officer at Acumen Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning and analysis. Zuga plays a crucial role in financial strategy and decision-making to ensure the financial health of Acumen.
